Separation of Trimethoprim and Sulfamethoxazol

Significance of the Topic

Simultaneous determination of trimethoprim and sulfamethoxazole is crucial in antibiotic quality control and therapeutic monitoring. Both compounds are widely prescribed as a fixed-dose combination, requiring accurate separation and quantification to ensure efficacy and safety.

Objectives and Study Overview

The primary objective was to establish a straightforward, reliable reversed-phase HPLC protocol for baseline separation of trimethoprim and sulfamethoxazole. The study focused on optimizing mobile phase composition, flow rate, and detection conditions to achieve high resolution within a reasonable analysis time.

Methodology and Instrumentation

Used Instrumentation:

• HPLC system operating in reversed-phase mode
• ProntoSIL 120-5 C18 SH column (250 mm × 4.0 mm, 5 µm particle size)
• Mobile phase: Methanol/Water with 1% formic acid (15:85 v/v), isocratic
• Flow rate: 1.0 mL/min, column temperature: 30 °C, injection volume: 10 µL
• UV detection at 220 nm

Main Results and Discussion

The optimized method achieved clear separation with retention times of approximately 4.5 minutes for trimethoprim and 7.8 minutes for sulfamethoxazole. Peak symmetry and resolution exceeded regulatory requirements. The isocratic run delivered reproducible peak areas with relative standard deviations below 1%.

Benefits and Practical Applications

This HPLC protocol supports routine QC of combined antibiotic formulations, offering rapid turnaround and minimal solvent consumption. Its simplicity makes it accessible for pharmaceutical laboratories and research facilities engaged in drug development or release testing.

Future Trends and Applications

Emerging trends include integrating ultra-high-performance liquid chromatography for faster separations, applying mass spectrometry detection for enhanced sensitivity, and adopting greener mobile phases to reduce environmental impact. Automation and on-line sample preparation are also anticipated developments.

Conclusion

A robust, reproducible reversed-phase HPLC method for the simultaneous analysis of trimethoprim and sulfamethoxazole has been validated. The approach fulfills industry standards for resolution, precision, and throughput, facilitating reliable antibiotic quality assessment.